ArticleJAMA network open2021

Association of Bcr-Abl Tyrosine Kinase Inhibitors With Hepatitis B Virus Reactivation Requiring Antiviral Treatment in Taiwan.

Ling-Yi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.